Quest Diagnostics Inc (DGX) City of Hope to Evaluate Quest Diagnostics’ Haystack MRD® for Guiding Patient Management in Multiple Cancers

Quest Diagnostics Inc (NYSE: DGX) FY 2026 Other Release

Newsdesk: